USE OF SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR AGONISTS FOR THE TREATMENT OF BRAIN DEGENERATIVE DISEASES.
摘要
<p>Disclosed is the use of sphingosine-1-phosphate (S1P) receptor agonists, preferably 2-amino-2- [2- (4-octylphenyl)ethyl] propane-1,3-diol, in the treatment of progressive dementia or brain degenerative diseases.</p>
